[en] Previous immunohistochemical data from our laboratory have demonstrated that expression of the 67 kD laminin receptor (67LR), a cancer-associated, high-affinity laminin-binding protein, is upregulated in ovarian carcinoma cells compared with normal serosal cells, and that this increased expression in cancer cells could be related to patient outcome. The aim of this study was to validate MLuC5, a monoclonal antibody that recognises the 67LR, as a tool to perform future immunohistochemical studies on larger populations of ovarian carcinoma patients. Expression of the 67LR was determined in 51 primary human ovarian carcinoma samples using immunohistochemistry and MLuC5. The 67LR was detected in ovarian carcinoma cell clusters of variable extent. Analysis of the data determined that 67LR expression was significantly increased in the samples from patients with disease progression, compared with those with no evidence of disease after completion of primary therapy, and in pooled grade 2 and 3 tumours compared to borderline and grade 1 tumours (P < 0.05, chi-squared test). No other significant correlation between 67LR expression and other clinicopathological parameters could be established. These data suggest that the 67LR is correlated to ovarian tumour progression. Detection of the 67LR using this monoclonal antibody could constitute an interesting parameter in prognosis determination of ovarian cancer.
1. Averette HE, Donato DM. Ovarian carcinoma. Advances in diagnosis, staging, and treatment. Cancer 1990, 65 (3 Suppl.), 703-708.
2. Young RC, Fuks Z, Hoskins WJ. Cancer of the ovary. In De Vita VT Jr, Hellman S, Rosenberg SA, eds. Cancer. Principles and Practice of Oncology, 3rd edition. Philadelphia, J.B. Lippincott, 1989, 1162-1196.
3. Liotta LA. Tumor invasion and metastases - role of the extracellular matrix: Rhoads Memorial Award lecture. Cancer Res 1986, 46, 1-7.
4. Castronovo V. Laminin receptors and laminin-binding proteins during tumor invasion and metastasis. Inv Metastasis 1993, 13, 1-30.
5. Rao NC, Barsky SH, Terranova VP, Liotta LA. Isolation of a tumor cell laminin receptor. Biochem Biophys Res Commun 1983, 111, 804-808.
6. Malinoff HL, Wicha MS. Isolation of a cell surface receptor protein for laminin from murine fibrosarcoma cells. J Cell Biol 1983, 96, 1475-1479.
7. Lesot H, Kuhl U, von der Mark K. Isolation of a laminin-binding protein from muscle cell membrane. EMBO J 1983, 2, 861-865.
8. Wewer UM, Taraboletti G, Sobet ME, Albrechtsen R, Liotta LA. Role of laminin receptor in tumor cell migration. Cancer Res 1987, 47, 5691-5698.
9. Sobel ME. Differential expression of the 67 kDa laminin receptor in cancer. Semin Cancer Biol 1993, 4, 311-317.
10. van den Brûle FA, Berchuck A, Bast RC, et al. Differential expression of the 67-kD laminin receptor and 31-kD human laminin binding protein in human ovarian carcinomas. Eur J Cancer 1994, 30A, 1096-1099.
11. Castronovo V, Colin C, Claysmith AP, et al. Immunodetection of the metastasis-associated laminin receptor in human breast cancer cells obtained by fine-needle aspiration biopsy. Am J Pathol 1990, 137, 1373-1381.
12. Martignone S, Pellegrini R, Villa E, et al. Characterization of two monoclonal antibodies directed against the 67 kDa high affinity laminin receptor and application for the study of breast carcinoma progression. Clin Exp Metast 1992, 10, 379-386.
13. Martignone S, Ménard S, Bufalino R, et al. Prognostic significance of the 67-kilodalton laminin receptor expression in human breast carcinomas. J Natl Cancer Inst 1993, 85, 398-402.
15. Russel P. The pathological assessment of ovarian neoplasms. III: The malignant 'epithelial' tumors. Pathology 1979, 11, 493.
16. Scully RE. Tumors of the ovary and maldeveloped gonads. In Atlas of Tumor Pathology, 2nd series. Washington, DC, Armed Forces Institutes of Pathology, 1979, Vol. 16.
17. Graham C, Karnovsky M. The early stages of absorption of horseradish peroxidase in the proximal tubules of mouse kidneys: ultrastructural cytochemistry by a new technique. J Histochem Cytochem 1966, 14, 291-390.
18. Hart IR, Fidler IJ. The implications of tumor heterogeneity for studies on the biology and therapy of cancer metastasis. Biochim Biophys Acta 1981, 651, 37-50.
19. Poste G, Greig R. The experimental and clinical implications of cellular heterogeneity in malignant tumors. J Cancer Res Clin Oncol 1983, 106, 159-170.
20. Nicolson GL. Generation of phenotypic diversity and progression in metastatic tumor cells. Cancer Metast Rev 1984, 3, 25-42.